We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Leads UK’s International Travel Testing Efforts in Response to New Omicron Variant

By LabMedica International staff writers
Posted on 02 Dec 2021

Randox Laboratories (Crumlin, UK) is leading the UK’s effort to expand PCR testing to support international travel in response to the emergence of the Omicron variant of COVID-19. More...

The outbreak of Omicron prompted the UK government to announce late on Saturday 27th November that it would stop accepting lateral flow tests as valid entry for international arrivals from Tuesday 30th November. The unexpected move has put pressure on the diagnostics industry to rapidly boost PCR testing efforts to ensure as little disruption as possible to international travel prior to and during the Christmas break. Randox has responded within 48 hours by returning international travel PCR capacity within its laboratories to 180,000 tests per day, with a potential to increase the number further. It has also immediately invested an additional GBP 10 million in consumable materials to enable high volume Day 2 PCR testing with next-day results.

Since the start of the pandemic, Randox has built, equipped and staffed over 80,000 square feet of PCR laboratories. In addition to its Northern Ireland facilities, it has opened further PCR laboratories in Manchester and Greater London and added 1,000 additional staff to support high volume PCR testing 24 hours a day, seven days a week, 365 days a year. Randox has processed over 21 million PCR tests to date, including more than 15 million for the UK’s National Testing Programme, and is the only laboratory in the UK to have processed over 100,000 PCR tests in a single day.

“Our 40 years of experience in testing and diagnostics have enabled us to rise to the challenges presented by this national and global crisis. We are proud to continue to provide an efficient service that represents value for money for both the National Testing Programme and the travelling public,” said a Randox spokesperson. “Having expanded our overall workforce in the face of this pandemic to over 3,300 we are well-placed to rapidly redeploy staff in response to the government’s fast decision to switch to PCR testing only for international travelers. These staff redeployments facilitate both laboratory testing and the high-volume preparation and dispatch of the critical sample collection kits that are essential to our service. We currently have a capacity for international travel of 180,000 PCR tests per day and we are confident we will be able to keep pace with demand for these essential tests.”

Related Links:
Randox Laboratories 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The portable platform could address diagnostic gaps for tuberculosis testing in clinics without access to advanced laboratory infrastructure (photo credit: Shutterstock)

Portable Test Detects Tuberculosis from Tongue Swabs in 30 Minutes

Despite decades of effective drug regimens, tuberculosis remains the leading cause of death from an infectious disease, driven in part by limited access to accurate, rapid testing. Conventional diagnostics... Read more

Pathology

view channel
Image: The researchers derived a gene-based signature and a blood test to help identify this high-risk subgroup (photo credit: Shutterstock)

New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease

Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage kidney disease, affecting 20%–40% of people with diabetes and more than 107 million individuals worldwide as of 2021.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.